/

Companies / Sironax

Sironax

Company

Sironax is committed to bringing new treatments to patients by targeting the underlying contributors of degeneration, including disrupted energy homeostatis, dysregulated cell death, and uncontrolled inflammation, across various organs and tissues.

Sironax has 1 investor on file, among them MSA Capital.

Investors

1 investor on file
InvestorEvidenceType
MSA CapitalPortfolio pageVenture capital

More from MSA Capital

27 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (23%), Fintech (20%), Consumer (9%).

See MSA Capital's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Sironax and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when MSA Capital adds a company.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/sironax.com.cn/investors

# also
GET /v1/companies/sironax.com.cn
GET /v1/companies/sironax.com.cn/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing